Home/Filings/4/0000899243-19-000654
4//SEC Filing

Agresta Samuel 4

Accession 0000899243-19-000654

CIK 0001113148other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:05 PM ET

Size

5.5 KB

Accession

0000899243-19-000654

Insider Transaction Report

Form 4
Period: 2019-01-04
Agresta Samuel
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-04+62,59662,596 total
    Exercise: $1.24Exp: 2029-01-04Common Stock (62,596 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.

Issuer

INFINITY PHARMACEUTICALS, INC.

CIK 0001113148

Entity typeother

Related Parties

1
  • filerCIK 0001748961

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:05 PM ET
Size
5.5 KB